Guideline for the management of Vitamin B12 deficiency
(For adults)
Anaemia or Strong Clinical suspicion e.g Visual disturbance, memory loss, psychiatric abnormalities, loss of peripheral nerve
function that can result in impaired sensation, movement or organ function with no other identifiable cause
Check vitamin B12
≥180 ng/L & no symptoms:
≥145 ng/L Offer pt dietary advice and recheck in 3 months. Pt
may purchase OTC cyanocobalamin 50-100mcg OD no further investigation
<145 ng/L
B12 dropped to Asymptomatic and B12 remains 145-180 Check IFAB
<145 ng/L B12 ≥180. Continue ng/L or ≥180 in pt with
with dietary control, no strong clinical suspiscion
Check Intrinsic Factor
further investigation
Antibody (IFAB) but proceed
to treatment regardless
Positive Negative
IM hydroxocobalamin 1mg x3/wk for 2 wks
Maintenance:
NO neurological Dietary cause: Oral cyanocobalamin 50-150mcg NO neuro
symptoms daily (OTC) symptoms Neuro NO neuro
Non-dietary cause: IM hydroxocobalamin 1000mcg symptoms symptoms
every 3 months for life s
Neurological Neuro
symptoms Seek *specialist advice (include IFAB result) symptoms
Management as per their advice but if immediately not
available, initiate treatment with:
*Specialist advice IM hydroxocobalamin 1mg every 2nd day Pt to continue with OTC Continue with
• Seek advice from most appropriate clinician, until no symptomatic improvement.
cyanocobalamin while dietary control
considering cause (gastro) or symptoms Maintenance – IM hydroxocobalamin 1000mcg every *specialist advice is sought (+/- oral
(neuro) or pt factors (Care of older person) 2-3 months for life – if advised by specialist. cyanocobalamin
• Remote advice usually sufficient. For
OTC), no further
MEHT: use ERS Advice and guidance. For
investigation
CHUFT, use Consultant Connect Specialist
• Refer to haematology if no prompt rise in Hb recommendation
(No need to recheck Vit B12 in pts on IM Tx. only Page 1 of 5
Use FBC to B12DeficiencyGUI201809V1.0FINAL
monitor response)
•
Medication/conditions that may affect levels Comments
Vitamin B12
Metformin (for longer than 12 months) Usually improved with dietary improvement of B12 intake
Only assess if objective evidence of deficiency is present including peripheral neuropathy or
macrocytic anaemia
If low levels check IFAB and should be treated with a short course of OTC oral
cyanocobalamin (50 micrograms orally for 4 weeks). Response should be assessed clinically
and continued if benefit is shown
No need for prophylactic B12 administration
Proton pump inhibitors and H2 antagonists OTC oral replacement (25-100 micrograms orally) may be appropriate if objective evidence of
deficiency is found
Anticonvulsants If no objective features of B12 deficiency- no need for replacement
OTC oral replacement (25-100 micrograms orally) may be appropriate if objective evidence of
deficiency is found
Oral contraceptives and hormone Only be assessed if objective symptoms develop and this is the only indication for treatment
replacement therapy OTC oral replacement (25-100 micrograms orally) may be appropriate if objective evidence of
deficiency is found
Colchicine Low levels can easily be increased with dietary supplementation
Antibiotics Low levels can easily be increased with dietary supplementation
Gastrointestinal surgery Both gastrectomy and bariatric surgery can lead to B12 deficiency and require regular
monitoring and replacement if levels are falling despite good dietary intake. Oral replacement
is often inadequate in these patients since the cause is likely malabsorption
Pregnancy Not routinely measured during pregnancy therefore only identified if symptoms develop – in
which case follow pathway as for non-pregnant people
Vegetarian and vegan diets Vegetarians and vegans are at increased risk of B12 deficiency especially during pregnancy
and when breastfeeding
Monitoring should be considered, especially at high-risk times, and OTC oral supplementation
(cyanocobalamin 50mcg daily) may be required
Page 2 of 5
B12DeficiencyGUI201809V1.0FINAL
Vitamin B12 frequently asked questions
1. If laboratory results show low (<145ng/L) vitamin B12 levels can oral supplementation be considered?
The NICE Clinical Knowledge of Summaries recommends that the intramuscular (IM) route should be used in all deficiency cases where there are
neurological symptoms as an acute dose (hydroxocobalamin 1mg on alternate days for two weeks). Usually IM will then be used as maintenance.
However, if the cause is dietary and the patient does not display neurological symptoms, OTC oral supplements may be used
2. What if the patient is unwilling to have the IM route?
If the deficiency is thought to be diet related and not due to lack intrinsic factor, then it is possible to use oral Cyanocobalamin. It is available as
cyanocobalamin 50mcg tablets which may be purchased over the counter. Parenteral therapy is preferable for deficient symptomatic patients, as it
is retained in the body for longer than oral tablets. Malabsorption is frequently a cause of deficiency, in such cases, oral supplements are unlikely to
be effective. This should be explained to the patient although any decision to inject will obviously require informed patient consent. If this is not
obtainable, the patient may choose to purchase OTC, but should be advised this may not be as effective as injection in their circumstances.
(Please note that Vitamin B Co strong tablets do not contain any vitamin b12 and therefore cannot be used to treat B12 deficiency)
3. How do you treat low vitamin B12 patients with Type 2 diabetes (on long term metformin longer than 12 months)?
Give patient dietary advice to increase their vitamin B12 levels, advise them to supplement with OTC oral cyanocobalamin. Monitor serum B12 every
6 months. If still low check IFAB. If positive, then treat lifelong with IM hydroxocobalamin every three months. If IFAB is negative, the reduced level
may be purely as a result of metformin, increase dose of oral cyanocobalamin to 150mcg daily, if still not able to raise B12 levels, treatment with three
injections of IM hydroxocobalamin with subsequent monitoring of serum B12 at 6 monthly intervals is suggested.
4. What if a person is still symptomatic despite maintenance IM vitamin B12 treatment?
If levels were borderline to begin with and only treated due to symptoms, then this suggests the B12 has not been effective. Trial withdrawal and
investigate other causes of symptoms. If initially B12 deficient, retest the B12 level: if remains low, seek specialist advice. If this is corrected to
normal levels, continue maintenance dose interval and investigate other causes of symptoms.
If a person's symptoms recur before the next injection is due, seek specialist advice from a haematologist.
5. What dose of cyanocobalamin is recommended for purchase?
If mild deficiency is thought to be diet related, advise people to take oral cyanocobalamin tablets 50–150 micrograms daily between meals. Doses
within this range are safe and sufficient to prevent dietary deficiency. Example products are shown on page 4.
6. What foods can I advise patients to eat to increase their dietary intake of Vitamin B12?
Foods that are a good source of B12: eggs, meat, milk and other dairy products, salmon and cod; as well as foods which have been fortified with B12
(some soy products, breakfast cereals and breads)
Page 3 of 5
B12DeficiencyGUI201809V1.0FINAL
Examples of cyanocobalamin available to purchase (other products are available)
Holland and Barrett (available on the high street or online):
100mcg vitamin B12 tablets x 100
Take ONE tablet daily
£7.49 (price at time of writing, also included in buy one get one half-price offer)
Nature’s Best (online)
100mcg vitamin B12 tablets x 100.
Take ONE tablet daily
£4.99 (price at time of writing, plus £1 delivery charge)
MyProtein (suitable for vegans)
1000mcg vitamin B12 tablets x 60
Take ONE tablet daily (dose is more than is necessary but will not cause harm)
£4.49 (price at time of writing)
Page 4 of 5
B12DeficiencyGUI201809V1.0FINAL
Title Guideline for the management of Vitamin B12 deficiency
(For adults)
Document reference B12DeficiencyGUI201809V1.0FINAL
Author Mid Essex CCG Medicines Optimisation Team
References [Link]
[Link]
Consulted with Emily Leach - Consultant Clinical Biochemist; NHS Mid Essex Medicines
Management Committee
Approved by Joint Mid Essex Area Prescribing Committee
Date approved September 2018
Next review date September 2020
Location in shared Prescribing/Medicines Guidance Current/BNF Chapter 9/Nutrition and Blood
drive
Location on MECCG [Link]
wesbite optimisation/clinical-pathways-and-medication-guidelines/chapter-9-nutrition-
and-blood-2
Page 5 of 5
B12DeficiencyGUI201809V1.0FINAL